ORSINGER OUT AT DEPUY SYNTHES. J&J REORGANIZES DEVICE BUSINESS (
Michel Orsinger is out as head of Johnson & Johnson's (J&J) DePuy Synthes orthopedics business following a reorganization of J&J’s medical device businesses.
Single Medical Devices Group
The company is creating a single Medical Devices Group by integrating its surgery and orthopedics business under the leadership of Gary Pruden, head of the surgery business. Pruden will become worldwide chairman, Johnson & Johnson Medical Devices. Orsinger told the company of his intention to pursue other opportunities outside J&J.
Orsinger was CEO of Synthes, Inc. when he helped arrange for J&J's $21.3 billion acquisition of Synthes in 2011. He reportedly received a $51.9 million parachute in the transaction. He then became head of J&J's combined DePuy Synthes orthopedics business.
Gary Pruden
Pruden is a sales guy, starting his career as a sales representative for Baxter Edwards. He joined J&J in 1985 with Janssen Pharmaceutical, Inc. in New Jersey and held a number of senior positions in sales, marketing, and strategic account management. In 2001, he was named vice president of marketing for the ...
